Correlation Between Holmen AB and Vicore Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Holmen AB and Vicore Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Holmen AB and Vicore Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Holmen AB and Vicore Pharma Holding, you can compare the effects of market volatilities on Holmen AB and Vicore Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Holmen AB with a short position of Vicore Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Holmen AB and Vicore Pharma.

Diversification Opportunities for Holmen AB and Vicore Pharma

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between Holmen and Vicore is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Holmen AB and Vicore Pharma Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vicore Pharma Holding and Holmen AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Holmen AB are associated (or correlated) with Vicore Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vicore Pharma Holding has no effect on the direction of Holmen AB i.e., Holmen AB and Vicore Pharma go up and down completely randomly.

Pair Corralation between Holmen AB and Vicore Pharma

Assuming the 90 days trading horizon Holmen AB is expected to generate 0.26 times more return on investment than Vicore Pharma. However, Holmen AB is 3.84 times less risky than Vicore Pharma. It trades about -0.01 of its potential returns per unit of risk. Vicore Pharma Holding is currently generating about -0.03 per unit of risk. If you would invest  42,099  in Holmen AB on August 25, 2024 and sell it today you would lose (1,299) from holding Holmen AB or give up 3.09% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Holmen AB  vs.  Vicore Pharma Holding

 Performance 
       Timeline  
Holmen AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Holmen AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, Holmen AB is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Vicore Pharma Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vicore Pharma Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Holmen AB and Vicore Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Holmen AB and Vicore Pharma

The main advantage of trading using opposite Holmen AB and Vicore Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Holmen AB position performs unexpectedly, Vicore Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vicore Pharma will offset losses from the drop in Vicore Pharma's long position.
The idea behind Holmen AB and Vicore Pharma Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities